-
Avantor Inaugurates Expanded Singapore Hub
Market news
PharmaSourcesJuly 12, 2023
On July 11, 2023,Avantor, Inc. inaugurated its expanded Singapore Hub which includes newly added cGMP manufacturing and a world class quality control laboratory.
-
InnoCare and Keymed Jointly Announce First Subject Dosed in Clinical Trial of CCR8 Monoclonal Antibody ICP-B05
Market news
PharmaSourcesFebruary 24, 2023
InnoCare Pharma and Keymed Biosciences that the first subject has been dosed in clinical trial of ICP-B05.
-
Malaysian Genomics to Offer World's First DNA-Driven Fertility Test
Market news
PharmasourcesFebruary 24, 2023
Group in strategic collaboration with Divine Genes to offer genetic tests related to reproductive health in Malaysia and overseas.
-
CPHI China opens for international partnering after China rises in CPHI Index
Market news
PharmaSources.comJune 08, 2022
CPHI & P-MEC China opens its online international partnering platform as pharmaceutical and biopharmaceutical industries in the country report strong underlying conditions and see increases in all categories of the most recent CPHI Pharma Index.
-
Study Result of Orelabrutinib in Patients with r/r MZL Published by American Journal of Hematology
Market news
PharmaSourcesSeptember 13, 2023
American Journal of Hematology recently published the study result of BTK (Bruton Tyrosine Kinase) inhibitor orelabrutinib in patients with relapsed or refractory (r/r) Marginal Zone Lymphoma (MZL).
-
InnoCare Pharma announced 2023 interim results as of 30 June 2023
Market news
PharmaSourcesSeptember 04, 2023
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced 2023 interim results as of 30 June 2023.
-
Vetter Earns Frost & Sullivan’s Customer Value Award for the Third Time
Market news
PharmaSourcesAugust 30, 2023
On August 29, 2023,Vetter has been awarded the Frost & Sullivan’s 2023 Global Customer Value Leadership Award in the aseptic fill-and-finish market for the company’s high performance for its customers.
-
T-CURX GmbH Announces Appointment of Two Industry Leaders to its Board of Directors
Market news
PharmaSourcesAugust 28, 2023
On August 28, 2023,T-CURX GmbH announces the appointments of Dr. Hans-Peter (HP) Gerber, PhD, as Chairman and of Dr. Bernd Eschgfäller, PhD, as an independent Board member.
-
Polpharma Biologics Announces FDA Approval of Tyruko® - First And Only Approved Biosimilar to Tysabri®* for Relapsing Forms of Multiple Sclerosis
Market news
PharmaSourcesAugust 28, 2023
On August 25, 2023,Polpharma Biologics announced today that the U.S. Food and Drug Administration (FDA) is the first regulatory body worldwide to approve the use of Tyruko®.
-
Sartorius and Repligen Corporation Launch Integrated System with Biostat STR® and XCell® ATF for Upstream Process Intensification
Market news
PharmaSourcesAugust 18, 2023
Sartorius and Repligen Corporation launch integrated system with Biostat STR® and XCell® ATF for upstream process intensification.
On July 11, 2023,Avantor, Inc. inaugurated its expanded Singapore Hub which includes newly added cGMP manufacturing and a world class quality control laboratory.
InnoCare Pharma and Keymed Biosciences that the first subject has been dosed in clinical trial of ICP-B05.
Group in strategic collaboration with Divine Genes to offer genetic tests related to reproductive health in Malaysia and overseas.
CPHI & P-MEC China opens its online international partnering platform as pharmaceutical and biopharmaceutical industries in the country report strong underlying conditions and see increases in all categories of the most recent CPHI Pharma Index.
American Journal of Hematology recently published the study result of BTK (Bruton Tyrosine Kinase) inhibitor orelabrutinib in patients with relapsed or refractory (r/r) Marginal Zone Lymphoma (MZL).
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced 2023 interim results as of 30 June 2023.
On August 29, 2023,Vetter has been awarded the Frost & Sullivan’s 2023 Global Customer Value Leadership Award in the aseptic fill-and-finish market for the company’s high performance for its customers.
On August 28, 2023,T-CURX GmbH announces the appointments of Dr. Hans-Peter (HP) Gerber, PhD, as Chairman and of Dr. Bernd Eschgfäller, PhD, as an independent Board member.
On August 25, 2023,Polpharma Biologics announced today that the U.S. Food and Drug Administration (FDA) is the first regulatory body worldwide to approve the use of Tyruko®.
Sartorius and Repligen Corporation launch integrated system with Biostat STR® and XCell® ATF for upstream process intensification.
Pharma Sources Insight APRIL 2023
